Efficacy and Safety of GLP-1 Agonists on Metabolic Parameters in Non-diabetic Patients with Inflammatory Bowel Disease.

Efficacy and Safety of GLP-1 Agonists on Metabolic Parameters in Non-diabetic Patients with Inflammatory Bowel Disease. Dig Dis Sci. 2024 Dec; 69(12):4437-4445.

View in: PubMed

subject areas

Adult
Body Mass Index
Cohort Studies
Crohn Disease
Female
Glucagon-Like Peptide 1
Glucagon-Like Peptides
Humans
Inflammatory Bowel Diseases
Male
Middle Aged
Obesity
Treatment Outcome
Weight Loss

authors with profiles

David Rubin
Silvana Pannain